Serina Therapeutics develops drug candidates using its POZ polymer delivery technology, with a lead treatment for Parkinson's disease. It last closed at $1.36 on Nov 17, down 2.50% on the day.
Only 1 firm rated SER in the past 90 days, not enough for a consensus
Average 12-month target
$8.00
▲ 486.1% upside
Based on 1 analyst who set a price target on SER in the past 90 days. The average target is $8.00, with a high of $8.00 and a low of $8.00, compared with the last close of $1.36.
Low $8.00Avg $8.00High $8.00
Blue marker: last close $1.36
Highest target$8.00
Average target$8.00
Lowest target$8.00
Latest rating changes
BTIGReiterated
Sep 10Buy$8
BTIGInitiated
Jul 1Buy$8
Date
Firm
Action
Rating
Price target
Sep 10
BTIG
Reiterated
Buy
$8
Jul 1
BTIG
Initiated
Buy
$8
Loading…
Technical Analysis
SER · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 18% below its 20 day and 38% below its 50 day average. It is 47% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 34), near oversold. The nearest support is the Pivot at $1.34, and the nearest resistance the Pivot R1 at $1.42.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 14.9%/day
Key levels
$4.2652 week high+213.2%
$2.11100 day average+55.1%
$2.01200 day average+47.8%
$1.8950 day average+39.0%
$1.6120 day average+18.4%
$1.55Swing high (Nov 12)+14.0%
$1.42Pivot R1+4.4%
$1.36Last close
$1.34Pivot−1.5%
$1.29Swing low (Nov 6)−5.1%
$1.28Pivot S1−5.9%
$1.2252 week low−10.3%
Indicators
RSI (14)
33.54
Weak, oversold below 30
Neutral
MACD
-0.15
Below its signal line
Bearish
Stochastic
9.0
Near the bottom of its range
Oversold
ADX (14)
25.5
Trending down
Williams %R
-91.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-113.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−23.7%
Change over 10 sessions
Bearish
ATR (14)
$0.20
Typical daily range, 14.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 31.4%/day
Key levels
$4.2652 week high+213.2%
$2.11100 day average+55.1%
$2.01200 day average+47.8%
$1.8950 day average+39.0%
$1.6120 day average+18.4%
$1.55Swing high (Nov 12)+14.0%
$1.42Pivot R1+4.4%
$1.36Last close
$1.34Pivot−1.5%
$1.29Swing low (Nov 6)−5.1%
$1.28Pivot S1−5.9%
$1.2252 week low−10.3%
Indicators
RSI (14)
37.68
Weak, oversold below 30
Neutral
MACD
-0.23
Below its signal line
Bearish
Stochastic
6.5
Near the bottom of its range
Oversold
ADX (14)
17.1
No clear trend
Williams %R
-93.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-163.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−38.5%
Change over 10 sessions
Bearish
ATR (14)
$0.43
Typical daily range, 31.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for SER
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SER did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow SER usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How SER has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SER is in one of them and how their past SER trades turned out.
Serina Therapeutics is a biotechnology company based in Huntsville, Alabama. It develops drug candidates that use its proprietary POZ polymer technology, which is designed to control how a drug is released and how long it stays active in the body. Its lead candidate, SER 252, is being developed to treat Parkinson's disease and is in clinical development. The company also plans to work with pharmaceutical partners on other uses of its platform, including RNA-based therapies and antibody drug conjugates.